BIONDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 42.704
EU - Europa 15.877
AS - Asia 4.876
SA - Sud America 70
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 38
OC - Oceania 25
Totale 63.640
Nazione #
US - Stati Uniti d'America 42.091
IT - Italia 3.529
SE - Svezia 2.736
IE - Irlanda 2.700
CN - Cina 2.684
DE - Germania 2.399
UA - Ucraina 1.625
HK - Hong Kong 1.109
GB - Regno Unito 880
CA - Canada 599
FI - Finlandia 494
VN - Vietnam 378
FR - Francia 320
RU - Federazione Russa 254
AT - Austria 241
TR - Turchia 241
IN - India 226
DK - Danimarca 196
BE - Belgio 144
NL - Olanda 132
JP - Giappone 63
SG - Singapore 52
IR - Iran 41
BR - Brasile 38
EU - Europa 38
CH - Svizzera 34
ES - Italia 31
BG - Bulgaria 30
RO - Romania 29
PL - Polonia 23
AU - Australia 21
GR - Grecia 19
NO - Norvegia 18
KR - Corea 15
EG - Egitto 11
CL - Cile 10
ID - Indonesia 10
TW - Taiwan 9
AR - Argentina 8
PE - Perù 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CZ - Repubblica Ceca 7
PH - Filippine 7
SC - Seychelles 7
PK - Pakistan 6
PT - Portogallo 6
RS - Serbia 6
GT - Guatemala 5
IL - Israele 5
MU - Mauritius 5
TH - Thailandia 5
A1 - Anonimo 4
AE - Emirati Arabi Uniti 4
AL - Albania 4
MX - Messico 4
MY - Malesia 4
NZ - Nuova Zelanda 4
RE - Reunion 4
ZA - Sudafrica 4
CR - Costa Rica 3
MK - Macedonia 3
NG - Nigeria 3
SA - Arabia Saudita 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BY - Bielorussia 2
CO - Colombia 2
DZ - Algeria 2
MD - Moldavia 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AP - ???statistics.table.value.countryCode.AP??? 1
BO - Bolivia 1
BT - Bhutan 1
CI - Costa d'Avorio 1
EC - Ecuador 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GL - Groenlandia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
PR - Porto Rico 1
TG - Togo 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
Totale 63.640
Città #
Ann Arbor 8.965
Woodbridge 4.519
Fairfield 4.225
Houston 3.487
Chandler 2.793
Dublin 2.604
Wilmington 2.424
Ashburn 2.165
Frankfurt am Main 1.863
Jacksonville 1.836
Seattle 1.678
Cambridge 1.458
Dearborn 1.266
New York 1.100
Hong Kong 1.096
Princeton 1.005
Milan 932
Nanjing 516
Lawrence 475
Altamura 461
Beijing 393
Lachine 309
San Diego 282
Shanghai 282
Vienna 233
Dong Ket 200
Andover 166
Helsinki 159
Boardman 153
Lissone 150
Nanchang 149
Brussels 133
Toronto 132
Guangzhou 131
Hebei 128
Rome 123
Shenyang 115
London 113
Changsha 103
Tianjin 100
Jinan 90
Fremont 86
Norwalk 85
Ottawa 83
Falls Church 82
Jiaxing 76
Hangzhou 74
Chicago 70
Fuzhou 66
Monza 62
Los Angeles 61
Huizen 60
Mountain View 59
Zhengzhou 59
Pune 57
Ningbo 55
Kocaeli 53
Kunming 48
Bergamo 46
Redmond 45
Turin 43
Edmonton 42
Padova 41
Bologna 39
Hefei 39
San Mateo 35
Taizhou 33
Grafing 29
University Park 28
Auburn Hills 26
Paris 25
Washington 25
Besana In Brianza 23
Carate Brianza 22
Philadelphia 22
Sacramento 22
Chengdu 21
Istanbul 21
Contursi 20
Genoa 19
Nürnberg 19
Perugia 19
Plovdiv 19
Leawood 18
Mumbai 17
Naples 17
Sesto San Giovanni 17
Tokyo 17
Bonndorf 16
Florence 16
São Paulo 16
Kilburn 15
Singapore 15
Brugherio 14
Detroit 14
Haikou 14
Hyderabad 14
Kiev 14
Tappahannock 14
Zanjan 14
Totale 50.633
Nome #
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 395
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 355
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 325
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 321
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 321
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 308
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 304
Acute myeloid leukaemia niche regulates response to L-asparaginase 298
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 297
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 296
NIPBL: a new player in myeloid cells differentiation 295
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 281
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 278
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 276
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 270
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 267
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 264
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 258
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 257
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 256
Moral distress in nurses in oncology and haematology units 250
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 247
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 245
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 244
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 243
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 242
Globalization of pediatric research: Pharmacological RCTs in Latin America 241
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing 241
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 234
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 233
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 230
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 226
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 225
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 224
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 223
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 223
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 222
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 219
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 219
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 218
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 217
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 216
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 214
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 212
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 212
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 211
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia 211
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 210
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 210
How I treat infant leukemia 210
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 209
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 207
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 205
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 204
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 203
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 202
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 200
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 199
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 198
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 197
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 196
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 195
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 192
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 192
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 191
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 190
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 190
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 189
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 189
Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen 188
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 186
Studio preliminare sul profilo emotivo di un campione di bambini guariti da leucemia linfoblastica acuta 185
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 185
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 185
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 185
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 184
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 184
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 183
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 182
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 179
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response 179
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 179
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 178
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 178
PO-345 Long-Term Survivors of Childhood Acute Lymphoblastic Leukaemia (ALL):Does Parents’Emotional Well-being Affect the Emotional Disposition of Their Survived Children? 178
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 177
Chimeric T-cell receptors: New challenges for targeted immunotherapy in hematologic malignancies 177
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 177
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis 177
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 176
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 175
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 175
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 175
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype 173
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia? 173
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 173
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 173
Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group 173
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 172
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy 171
Totale 21.977
Categoria #
all - tutte 200.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.890 0 0 0 0 0 0 0 0 0 0 1.376 1.514
2019/202012.994 1.500 875 919 1.179 1.276 1.587 1.709 890 1.216 711 799 333
2020/202111.714 571 772 1.243 1.147 881 1.045 1.103 1.075 915 1.207 725 1.030
2021/20227.508 529 839 954 528 429 516 350 389 572 540 597 1.265
2022/202311.443 1.446 3.419 837 1.012 708 1.706 191 671 746 94 407 206
2023/20247.822 303 290 436 479 1.135 2.273 1.637 319 754 190 6 0
Totale 66.364